This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sigma-Chemist Warehouse deal gets Australian regulatory approval, with conditions

By Saloni Sinha ( November 7, 2024, 03:22 GMT | Insight) -- Australian pharmacy giant CW Group, the owner of the Chemist Warehouse chain, has received regulatory approval for its high-profile reverse merger with Sigma Healthcare, close to a year after first announcing the tie-up. The Australian competition regulator’s approval is subject to court-enforceable undertakings, including allowing Sigma franchisees who signed contracts prior to Jan. 1, 2024, to terminate their agreements “should they choose to do so.” This would apply for a period of three years. Australian pharmacy giant CW Group, the owner of the Chemist Warehouse chain, has received regulatory approval for its high-profile reverse merger with Sigma Healthcare, close to a year after first announcing the tie-up....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login